May 2013 saw the publication of the first European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) comprehensive and multi-dimensional package providing information on European drug trends and developments (European Monitoring Centre for Drug and Drug Addiction, 2013a) alongside focused analyses and country level data. This article presents highlights from the EDR package, which can be accessed in its entirety at: www.emcdda.europa.eu.
This abstract is provided here as a convenience only. Check the publisher's website (if available) for the definitive version.
There is no abstract available for thisd article.